JOURNAL OF THROMBOSIS AND HAEMOSTASIS Journal
Overview
publication venue for
- The identification of at-risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTH. 16:175-180. 2018
- CD32 antibodies protect FCGR2A mice from IGG mediated hypersensitivity reactions and thrombosis 2015
- Clinical significance of circulating tissue factor (TF) in women with suspected ovarian cancer 2015
- Converging roles of platelets and CD32A in IGG-mediated hypersensitivity reactions 2015
- Impact of overdiagnosis of HIT in a large community hospital 2015
- CalDAG-GEFI deficiency protects mice from Fc gamma RIIa-mediated thrombotic thrombocytopenia induced by CD40L and beta 2GPI immune complexes. 12:2113-2119. 2014
- Microparticle association and heterogeneity of tumor-derived tissue factor in plasma: is it important for coagulation activation?. 12:186-196. 2014
- Assessment of protein C anticoagulant pathway by thrombin generation assay in the presence of endothelial cells 2013
- CalDAG-GEFI deficiency protects mice from FcyRIIa-mediated thrombotic thrombocytopenia induced by CD40L and beta 2GPI immune complexes 2013
- Endothelial cell-based fluorogenic thrombin generation assay for the evaluation of the protein C anticoagulant system 2013
- The use of thrombin generation assay in plasma and whole blood for the evaluation of coagulability in patients with different stages of liver disease 2011
- Effect of the small molecule plasminogen activator inhibitor-1 (PAI-1) inhibitor, PAI-749, in clinical models of fibrinolysis. 8:1333-1339. 2010
- Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice. 7:171-181. 2009
- Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis. 6:1558-1564. 2008
- Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. 6:1517-1524. 2008
- Experimental metastasis and primary tumor growth in mice with hemophilia A. 4:1056-1062. 2006
- Antimetastatic effect of tinzaparin, a low-molecular-weight heparin. 1:1972-1976. 2003
Research
category
- HEMATOLOGY Web of Science Category
- PERIPHERAL VASCULAR DISEASE Web of Science Category
Identity
International Standard Serial Number (ISSN)
- 1538-7933
Electronic International Standard Serial Number (EISSN)
- 1538-7836
Other
journal abbreviation
- J THROMB HAEMOST